FDIC Advisory Committee to Discuss 2013 Economic Inclusion Pri...

(FIND, Inc. via COMTEX) -- SUMMARY: In accordance with the Federal Advisory Committee Act, notice is hereby given of a meeting of the FDIC Advisory Committee on Economic Inclusion, which will be held in Washington, DC. The Advisory Committee will ...

Shepherd is a member of the FDIC Advisory Committee on Economic Inclusion, providing advice and recommendations to the FDIC on important initiatives focused on expanding access to banking services for underserved populations. He also serves on the ...

Overview Monroe Capital Corporation is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company under the 1940 Act. In addition for tax purposes, we intend to ...

by Chair Mary Jo White U.S. Securities and Exchange Commission Before the U.S. House of Representatives Committee on Financial Services May 16, 2013 Chairman Hensarling, Ranking Member Waters and Members of the Committee: Thank you for the ...

We use statistics and statistical tools extensively to aid informed policy making. Therefore, a solid statistical grounding and soiling the hands with data are basic prerequisites for the making of a good empirical economist. (Opening Remarks by ...

APPROVED 2012 FINANCIAL STATEMENTS DIVIDEND OF EURO 0.041 PER SHARE APPOINTED THE NEW BOARD OF DIRECTORS APPROVED NEW TREASURY SHARES PLAN Extension of the last term for the exercise of the warrants The Shareholders' Meeting of Tamburi Investment ...

The TGA is seeking comments from interested parties on advisory statements for cetirizine, when included in non-prescription medicines for oral use, which are proposed for inclusion in the Required Advisory Statements for Medicine Labels (RASML) ...

The trustees of the IFRS Foundation have included the U.S. Financial Accounting Standards Board among the national and regional standard-setters in the new Accounting Standards Advisory Forum, the new group that will advise the International ...

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/15/13 -- Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today reported financial results for the first quarter ended March 31, 2013. Net income for the quarter ended March 31, 2013 was approximately $6.0 ...